Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapy.
Andrew P HearnOliver D HugZiana A SomaniJoanne KavanaghGrainne d'AnconaCris RoxasLinda GreenLouise ThomsonMariana FernandesBrian D KentJaideep DhariwalAlexandra M NanzerAlexandra M NanzerPublished in: The European respiratory journal (2021)